Company Filing History:
1 out of 832,812 Years Active: 2015
Title: Jean-Pierre Dumonteix: Innovator in Pharmaceutical Solutions for Diabetes
Introduction
Jean-Pierre Dumonteix is an inventive mind located in Villenave d'Ornon, France. He has made significant contributions to the field of pharmaceutical technologies, particularly focusing on methods that assist in the management of diabetes. With one patented invention, his work aims to address critical health challenges faced by individuals with type II diabetes.
Latest Patents
Dumonteix holds a patent for a "Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type II diabetes." The innovative method involves a hydroalcoholic solution that contains at least one hypoglycemia-inducing or insulinotropic active principle. Notably, this formulation is designed for trans-buccal mucosal application, featuring a reduced dosage (30% to 50% less than the usual oral unit dosage) for effective spot treatment of postprandial hyperglycemia in humans or animals. The patent also outlines a specific preparation method and its application in managing postprandial hyperglycemia (PPHG) associated with type II diabetes.
Career Highlights
Throughout his career, Dumonteix has demonstrated a commitment to advancing medical treatment options for diabetes patients. His patented method not only showcases his innovative spirit but also highlights the potential for reducing medication dosage while maintaining efficacy. This approach could significantly improve patient compliance and health outcomes in diabetes management.
Collaborations
During his professional journey, Dumonteix has collaborated with notable colleagues, including Philippe Perovitch and Marc Maury. These partnerships reflect a strong network of innovative thinkers within the pharmaceutical field, as they work together to push the boundaries of current treatment methodologies for diabetes.
Conclusion
Jean-Pierre Dumonteix stands as a remarkable inventor whose work focuses on improving the lives of those managing type II diabetes. With his patented method for pharmaceutical compositions aimed at treating hyperglycemia, he has made a significant impact in the pharmaceutical sector. His innovative approach and collaborations with other professionals underline the importance of teamwork in the pursuit of medical advancements.